Comparison of hematological parameters and perinatal outcomes between COVID-19 pregnancies and healthy pregnancy

Esin Merve Erol Koç1, Rahime Bedir Fındık1, Hatice Akkaya1

  • 1Department of Obstetrics and Gynecology, Ankara City Hospital, Ankara, Turkey.

Insights

Pregnancies with Coronavirus Disease 2019 (COVID-19) did not show adverse perinatal outcomes. Hematologic parameters, like monocyte/lymphocyte ratio (MLR), may aid in diagnosing COVID-19 in pregnant individuals.

Area of Science:

  • Obstetrics and Gynecology
  • Infectious Diseases
  • Hematology

Background:

  • Pregnancy involves significant physiological changes that can alter immune responses and hematologic parameters.
  • Coronavirus Disease 2019 (COVID-19) poses unique challenges during pregnancy, necessitating understanding of its impact on maternal and fetal well-being.

Purpose of the Study:

  • To investigate the association between COVID-19 infection in pregnancy and adverse perinatal outcomes.
  • To assess the diagnostic utility of specific hematologic indices in pregnancies complicated by COVID-19.

Main Methods:

  • A cohort study comparing 39 pregnant individuals with COVID-19 to 69 unaffected pregnant individuals.
  • Analysis of perinatal outcomes and complete blood count indices at admission.

Main Results:

  • No significant differences in obstetric or neonatal outcomes, except for an increased Cesarean section rate in the COVID-19 group (p=0.026).
  • Elevated monocyte count, red cell distribution width (RDW), neutrophil/lymphocyte ratio (NLR), and monocyte/lymphocyte ratio (MLR) were observed in COVID-19 pregnancies.
  • Decreased mean platelet volume (MPV) and plateletcrit were noted; MLR showed high specificity (96.7%) for COVID-19 diagnosis in pregnant individuals.

Conclusions:

  • COVID-19 in pregnancy is not linked to adverse perinatal outcomes.
  • The monocyte/lymphocyte ratio (MLR) can serve as a supportive diagnostic marker for COVID-19 in pregnant populations, complementing RT-PCR testing.
Abstract